DEPO PROVERA - BONE LOSS ISSUES BIBLIOGRAPHY

1. Contraceptives and teens: what are the options? Contracept Technol Update. Sep 2000;21(9):109-111.
Link to PubMed

2. Bahamondes L, Perrotti M, Castro S, Faundes D, Petta C, Bedone A. Forearm bone density in users of Depo-Provera as a contraceptive method. Fertil Steril. May 1999;71(5):849-852.
Link to PubMed

3. Banks E, Berrington A, Casabonne D. Overview of the relationship between use of progestogen-only contraceptives and bone mineral density. Bjog. Dec 2001;108(12):1214-1221.
Link to PubMed

4. Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol. May 2004;103(5 Pt 1):899-906.
Link to PubMed

5. Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol. Oct 2001;98(4):576-582.
Link to PubMed

6. Busen NH. Bone mineral density in adolescent women using depot medroxyprogesterone acetate. J Am Acad Nurse Pract. Feb 2004;16(2):57-62.
Link to PubMed

7. Busen NH, Britt RB, Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. J Adolesc Health. Apr 2003;32(4):257-259.
Link to PubMed

8. Clark MK, Sowers MR, Nichols S, Levy B. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril. Dec 2004;82(6):1580-1586.
Link to PubMed

9. Cromer BA. Bone mineral density in adolescent and young adult women on injectable or oral contraception. Curr Opin Obstet Gynecol. Oct 2003;15(5):353-357.
Link to PubMed

10. Cromer BA. Effects of hormonal contraceptives on bone mineral density. Drug Saf. Mar 1999;20(3):213-222.
Link to PubMed

11. Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr. Nov 1996;129(5):671-676.
Link to PubMed

12. Cromer BA, Lazebnik R, Rome E, et al. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. Am J Obstet Gynecol. Jan 2005;192(1):42-47.
Link to PubMed

13. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health. Dec 2004;35(6):434-441.
Link to PubMed

14. Cundy T, Cornish J, Roberts H, Elder H, Reid IR. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol. Oct 1998;92(4 Pt 1):569-573.
Link to PubMed

15. Cundy T, Cornish J, Evans MC, Roberts H, Reid IR. Recovery of bone density in women who stop using medroxyprogesterone acetate. Bmj. Jan 22 1994;308(6923):247-248.
Link to PubMed

16. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Bmj. Jul 6 1991;303(6793):13-16.
Link to PubMed

17. Gbolade B, Ellis S, Murby B, Randall S, Kirkman R. Bone density in long term users of depot medroxyprogesterone acetate. Br J Obstet Gynaecol. Jul 1998;105(7):790-794.
Link to PubMed

18. Gordon CM, Nelson LM. Amenorrhea and bone health in adolescents and young women. Curr Opin Obstet Gynecol. Oct 2003;15(5):377-384.
Link to PubMed

19. Harkins GJ, Davis GD, Dettori J, Hibbert ML, Hoyt RA. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report. J Reprod Med. Mar 1999;44(3):309-312.
Link to PubMed

20. Kaunitz AM. Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol. May 1994;170(5 Pt 2):1543-1549.
Link to PubMed

21. Kaunitz AM. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. Int J Fertil Womens Med. Mar-Apr 1998;43(2):73-83.
Link to PubMed

22. Kaunitz AM. Long-acting hormonal contraception: assessing impact on bone density, weight, and mood. Int J Fertil Womens Med. Mar-Apr 1999;44(2):110-117.
Link to PubMed

23. Lara-Torre E, Edwards CP, Perlman S, Hertweck SP. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. Feb 2004;17(1):17-21.
Link to PubMed

24. Lloyd T, Lin HM, Eggli DF, Dodson WC, Demers LM, Legro RS. Adolescent Caucasian mothers have reduced adult hip bone density. Fertil Steril. Jan 2002;77(1):136-140.
Link to PubMed

25. Mark S. Premenopausal bone loss and depot medroxyprogesterone acetate administration. Int J Gynaecol Obstet. Dec 1994;47(3):269-272.
Link to PubMed

26. Mehta S. Bone loss, contraception and lactation. Acta Obstet Gynecol Scand. Apr 1993;72(3):148-156.
Link to PubMed

27. Merki-Feld GS, Neff M, Keller PJ. A prospective study on the effects of depot medroxyprogesterone acetate on trabecular and cortical bone after attainment of peak bone mass. Bjog. Jul 2000;107(7):863-869.
Link to PubMed

28. Merki-Feld GS, Neff M, Keller PJ. A 2-year prospective study on the effects of depot medroxyprogesterone acetate on bone mass-response to estrogen and calcium therapy in individual users. Contraception. Feb 2003;67(2):79-86.
Link to PubMed

29. Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women. Clin Endocrinol (Oxf). Nov 1998;49(5):615-618.
Link to PubMed

30. Ott SM, Scholes D, LaCroix AZ, Ichikawa LE, Yoshida CK, Barlow WE. Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab. Jan 2001;86(1):179-185.
Link to PDF

31. Paiva LC, Pinto-Neto AM, Faundes A. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive. Contraception. Dec 1998;58(6):351-355.
Link to PubMed

32. Perrotti M, Bahamondes L, Petta C, Castro S. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate. Fertil Steril. Sep 2001;76(3):469-473.
Link to PubMed

33. Rome E, Ziegler J, Secic M, et al. Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive. J Pediatr Adolesc Gynecol. Dec 2004;17(6):373-377.
Link to PubMed

34. Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol. Feb 1999;93(2):233-238.
Link to PubMed

35. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. Feb 2005;159(2):139-144.
Link to PubMed

36. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women. Contraception. Feb 2004;69(2):99-104.
Link to PubMed

37. Sowers MF, Scholl T, Harris L, Jannausch M. Bone loss in adolescent and adult pregnant women. Obstet Gynecol. Aug 2000;96(2):189-193.
Link to PubMed

38. Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors. Contraception. Jul 1997;56(1):1-3.
Link to PubMed

39. Westhoff C. Bone mineral density and DMPA. J Reprod Med. Sep 2002;47(9 Suppl):795-799.
Link to PubMed

40. Westhoff C. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes. J Reprod Med. May 1996;41(5 Suppl):401-406.
Link to PubMed